NCT06229912 2026-02-19A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesM.D. Anderson Cancer CenterPhase 2 Recruiting40 enrolled
NCT05761171 2025-12-22A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory LeukemiaChildren's Oncology GroupPhase 2 Active not recruiting78 enrolled